Comparison of ASE values with 95% bootstrap confidence intervals (CIs) and paired <i>t</i>-test <i>p</i>-values for BP() and NB() under equal sample sizes (). by Mahmut Sami Erdoğan (22097195)

Subjects:

R source code for real data applications using the proposed NURBS-based ROC estimator. by Mahmut Sami Erdoğan (22097195)

Subjects:

Estimated ROC curves with 95% bootstrap confidence bands for four nonparametric methods based on the FC dataset. by Mahmut Sami Erdoğan (22097195)

Subjects:

ASE values of eight different estimators for the last three different scenarios. by Mahmut Sami Erdoğan (22097195)

Subjects:

Comparison of ASE values with 95% bootstrap confidence intervals (CIs) and paired <i>t</i>-test <i>p</i>-values for NB6 vs kROC estimators under equal sample sizes (). by Mahmut Sami Erdoğan (22097195)

Subjects:

Estimated ROC curves with 95% bootstrap confidence bands for four nonparametric methods based on the HL dataset. by Mahmut Sami Erdoğan (22097195)

Subjects:

Comparison of ASE values with 95% bootstrap confidence intervals (CIs) and paired <i>t</i>-test <i>p</i>-values for NB6 vs BP6 estimators under equal sample sizes (). by Mahmut Sami Erdoğan (22097195)

Subjects:

Estimated ROC curves with 95% bootstrap confidence bands for four nonparametric methods applied to the U96113_at gene. by Mahmut Sami Erdoğan (22097195)

Subjects:

Estimated ROC curves with 95% bootstrap confidence bands for four nonparametric methods applied to the U46006_s_at gene. by Mahmut Sami Erdoğan (22097195)

Subjects:

ASE values of eight different estimators for the first three different scenarios. by Mahmut Sami Erdoğan (22097195)

Subjects:

Maps of median projected λ_<i>S</i> (a) and <i>R</i>₀ (b) across 1st-level sub-national administrative regions in selected South American countries. by Keith Fraser (1868587)

Changes in AL (A) and SE (B) according to the treatment time estimation curve in patients given 0.125% atropine. by Zi-Rong Chen (9227618)

“…<p><b>(A)</b> The crucial period and outcome measurement period in the current study. …”

Crude and age-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

Crude and type-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

Crude and residence-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

Comparison of rank correlation analysis results across groups of combinations - B1-B5 vs. C1-C10 vs. D1-D10. by Roman Vavrek (13200141)

Data Sheet 1_Cytotoxic CD4+ T-follicular cells may mediate killing against lymphoma cells.pdf by Yin Xiao (447102)

“…In this study, we aim to elucidate their presence and functional relevance in two different lymphoma subtypes, follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL). Flow cytometric analysis of tonsillar versus FL-cell suspensions revealed a heightened number of GZMK⁺NKG7/TIA-1⁺ T_F_K cells in the latter, accompanied by a significant increase in T-regulatory and T-follicular regulatory (T_FR) cells. …”

Age-adjusted annual percent changes (APC) in incidence (A), mortality (B), and prevalence (C) rates per 100,000 over 2014–2023 for both sexes and sex-specific. by Ayana Ablayeva (22103708)

Comparison of agreement in the order based on the SD-TOPSIS technique across groups of combinations - B1-B5 vs. C1-C10 vs. D1-D10. by Roman Vavrek (13200141)

GS-1: Comparison of estimates of people for dataset A (left bar) and B (right bar) per region. Discrepancies occur in areas the Czech Republic and SE Germany. by Isabell Schmidt (6331013)